Ginkgo and DeepLife Partner to Unlock Causal Drug Mechanisms from High-Throughput Transcriptomics

DeepLife Welcomes Two New Advisors

Inoviem Scientific and DeepLife partner to advance novel target discovery in IBD 

CloudScientific and DeepLife Partner to Bring AI-Powered Virtual Cell Technology to China

Single-cell insights into immunotherapy response in head and neck cancer : a DeepLife & CLB collaboration

Drug repositioning explained: using drug target affinity prediction to identify new opportunities

DeepLife selected as France 2030 “Pionniers de l’IA” laureate for ONCODECIDE project

TwinCell: AI-based Virtual Cell for reliable and interpretable Target Identification

TwinBench: Toward unbiased Virtual Cells benchmarks

DeepLife in 2025: AI + Digital Twins of Cells Driving Innovation

PANC-CKI Consortium Unites AI, Organoids and CK1 Inhibition to Crack Pancreatic Cancer’s Defenses

From lab to production: streamlining biotech R&D

Advancing precision therapies for pediatric liver cancer with the SignalWise project

Scalable data architecture for biomedical discovery

DeepLife: Drug Discovery at the Cellular Scale [FR]

Benchmarking interactomes: quality over quantity in molecular networks